29 / 30
•
mCRC mutations can be easily detected in plasma by different
techniques, NGS is close.
•
RAS
MAF is a prognostic factor in 1st and 2nd line of treatment for mCRC.
•
The underlying biological or molecular mechanisms that contribute to or
modulate plasma MAFs are still to be determined.
Conclusions